Navigation Links
GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011
Date:11/2/2011

GAITHERSBURG, Md., Nov. 2, 2011 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the third quarter of 2011 on Wednesday, November 9, 2011, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EST to discuss the company's third quarter financial results and business outlook.

To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980 (international) and use the following Conference ID: 23292607. An audio replay of the conference call will be available starting at 1:00 p.m. EST on November 9, 2011 through November 16, 2011. To listen to the audio replay, dial 855-859-2056 or 404-537-3406 and use Conference Replay ID: 23292607.

To access the webcast or the replay, go to www.genvec.com, click on "Investors and Media," and click on "Events and Presentations."

About GenVecGenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus type 2 (HSV-2), dengue fever, and malaria. In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD). Additional information about GenVec is available at
'/>"/>

SOURCE GenVec, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
2. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
3. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
4. GenVec Reports Third Quarter 2010 Financial Results
5. GenVec Forms Collaboration With World-Leading Animal Health Company
6. GenVec Reports Fourth Quarter and 2010 Year-End Financial Results
7. GenVec to Host First Quarter 2011 Earnings Call and Webcast
8. GenVec Elects Adel A.F. Mahmoud and Edward M. Connor, Jr. to Board of Directors
9. GenVec Reports Second Quarter 2011 Financial Results
10. GenVec to Present at Stifel Nicolaus 2011 Healthcare Conference
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014   Zacks Equity Research highlights Epizyme ... the Day and Panera (Nasdaq: PNRA - Free Report ) ... provides analysis on Amicus Therapeutics (Nasdaq: FOLD - Free Report ... (Nasdaq: SHPG - Free Report ). Here is ... of the Day : The biotech bull market ...
(Date:8/22/2014)... Research and Markets has announced the addition ... Report 2014" report to their offering. ... 2014 is a professional and in-depth study on the ... a focus on the Chinese situation. The report ... classifications, applications and industry chain structure. The particulate respirators ...
(Date:8/22/2014)... , Cali ., Aug. 22, 2014 ... Papillomavirus Conference shows that a therapy being developed by Hera ... two that cause 70 percent of all cervical cancer. ... blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according ... Broker , Ph.D., who presented the findings at the ...
Breaking Medicine Technology:Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Global and Chinese Particulate Respirators Industry Report 2014 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
... DIEGO, Jan. 31, 2011 Volcano Corporation (Nasdaq: ... of Massachusetts has issued a decision that ruled in ... Inc., and against LightLab Imaging, Inc., on all of ... 11-page decision also rejected LightLab,s request for injunctive relief. ...
... its continuing partnerships with Brazilian public health authorities and ... Mr. Nelson dos Santos as interim vice president of ... nonprofit organization whose mission is to improve the health ... programs that help ensure the quality, safety and benefit ...
Cached Medicine Technology:Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case 2New Interim Leadership for USP-Brazil 2
(Date:8/22/2014)... Key West Health & Beauty’s ( http://www.keywesthealthandbeauty.com ... anticipated study results of the 12 best and worst ... accompanying infographic on their website. It appears that the ... impact on the skin and contribute to many unwanted ... asked how they determined the results, founder and skin ...
(Date:8/22/2014)... Medical Oncology (ESMO), the leading pan-European organisation representing ... three outstanding individuals receiving the Society,s esteemed annual ... Bokemeyer, Heikki Joensuu and Peter Boyle on the ... Madrid, Spain. , Carsten Bokemeyer will receive the ... transition of cancer discovery into real benefit at ...
(Date:8/22/2014)... in Sweden provides insight on how the brain processes ... different sources and sides of the body, in order ... are presented in the journal Neuron , show ... various types of sensory information, with specialised functional roles ... the main input structure in the basal ganglia, and ...
(Date:8/22/2014)... Oncology (ESMO), the leading pan-European organisation representing medical ... outstanding individuals receiving the Society,s esteemed annual awards. ... Heikki Joensuu and Peter Boyle on the occasion ... Spain. , Carsten Bokemeyer will receive the ESMO ... of cancer discovery into real benefit at patient ...
(Date:8/22/2014)... air in American cities is getting safer to breathe, ... progress has been made in reducing levels of harmful ... said in a news release. Since 1990, there ... from human sources such as coal-fired plants, a 66 ... in lead, which harms brain development in children. ...
Breaking Medicine News(10 mins):Health News:Key West Health & Beauty Announces The 12 Best & Worst U.S. Cities For Skin Study 2Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:The striatum acts as hub for multisensory integration 2Health News:ESMO honours outstanding oncology professionals 2Health News:ESMO honours outstanding oncology professionals 3Health News:Air in U.S. Cities Getting Cleaner, EPA Says 2
... food cravings and keeping them in check may be ... first six-month phase of the study provides new insights ... their role in weight control. ,Cravings are ... Susan Roberts, PhD, director of the USDA HNRCAs Energy ...
... typically graduate students hired to help undergrads with their ... expert Bernardo J. Carducci said social assistants, people ... and social skills, should become staples, as well. ... Research Institute at IU Southeast, are no different than ...
... industrial body recognizing the downward trend of access to quality ... reverse the situation- more money and a significant private-public partnership. ... Chambers of Commerce and Industry (FICCI), India needs to spend ... of achieving 'Health for all' is to be attained by ...
... is considered a healthy role model the world over, but ... land of the rising sun. ,Japan's health ministry estimates ... age of 40 is obese and experts have identified a ... ,"The everyday habits among the Japanese have become ...
... what boys lose in the process of circumcision turns ... penis. ,The long-term-health impact of neo-natal ... circumcision on sexual function in the adult male have ... recent study, by M. Sorrels and colleagues from the ...
... but they plan to add to their family in a big way ... Stewart inquired as to just how many kids Angelina wanted in all, ... as many as 14 little ones. ,"Hmm, it fluctuates between ... tewart then praised her by saying, "Wow, I'll tell you this: I ...
Cached Medicine News:Health News:Weight Management Achieved by Controlling and Not Suppressing Food Cravings 2Health News:Binge Drinking on College Campuses is a Matter of Fear, Not Freedom 2Health News:Binge Drinking on College Campuses is a Matter of Fear, Not Freedom 3Health News:FICCI Proposes Models To Solve Indias Healthcare Crisis 2Health News:Japanese are Weighed Down by Deviating from Their Traditional Diet 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 7.0 mm and length 7.7 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 12 mm....
Medicine Products: